The bladder cancer cells treated with Ad5F11p-E1A plus cisplatin expressed higher proteins of p53, Bax, and cleaved caspase-3 than the cells treated with Ad5F11p- E1A or cisplatin alone. Here, BAX is linked to urinary bladder cancer.